[
  {
    "id": "8054d46a-061a-4aa5-a53d-1acdc1cfd800",
    "symptom": "Pain",
    "severityLevel": "Mild (1-3)",
    "recommendations": {
      "escalation": "If pain >3/10 or affecting function",
      "monitoring": [
        "Daily pain scores",
        "Functional assessment"
      ],
      "pharmacological": [
        "Acetaminophen 1000mg q6h",
        "NSAIDs if appropriate"
      ],
      "nonPharmacological": [
        "Heat/cold therapy",
        "Gentle exercise",
        "Relaxation techniques"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Adult Cancer Pain Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:05.785Z",
    "updatedAt": "2025-06-30T12:51:05.785Z"
  },
  {
    "id": "6be9aff8-3a21-4b67-a003-5c786a52f6e3",
    "symptom": "Pain",
    "severityLevel": "Moderate (4-6)",
    "recommendations": {
      "escalation": "If pain >6/10 or uncontrolled",
      "monitoring": [
        "Q4h pain assessment",
        "Bowel regimen",
        "Sedation score"
      ],
      "pharmacological": [
        "Morphine 5-10mg PO q4h PRN",
        "Oxycodone 5mg PO q4h PRN"
      ],
      "nonPharmacological": [
        "Physical therapy",
        "TENS unit",
        "Mindfulness"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Adult Cancer Pain Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:05.785Z",
    "updatedAt": "2025-06-30T12:51:05.785Z"
  },
  {
    "id": "25505e57-5d68-4ebf-9f4a-c65b4f734aec",
    "symptom": "Pain",
    "severityLevel": "Severe (7-10)",
    "recommendations": {
      "escalation": "Pain specialist consultation within 24h",
      "monitoring": [
        "Hourly assessment",
        "Respiratory status",
        "Sedation"
      ],
      "pharmacological": [
        "Morphine 10-20mg PO q4h",
        "Consider IV/SQ route",
        "Breakthrough dosing"
      ],
      "nonPharmacological": [
        "Immediate comfort measures",
        "Family support"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Adult Cancer Pain Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:05.785Z",
    "updatedAt": "2025-06-30T12:51:05.785Z"
  },
  {
    "id": "f4819288-45f6-4185-aac7-89bf55532a97",
    "symptom": "Nausea",
    "severityLevel": "Mild",
    "recommendations": {
      "escalation": "If persistent >48h or affecting nutrition",
      "monitoring": [
        "Daily symptom assessment",
        "Nutritional intake"
      ],
      "pharmacological": [
        "Ondansetron 4mg PO q8h PRN",
        "Metoclopramide 10mg PO qid"
      ],
      "nonPharmacological": [
        "Small frequent meals",
        "Ginger tea",
        "Aromatherapy"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Antiemesis Guidelines v2.2025",
    "createdAt": "2025-06-30T12:51:05.785Z",
    "updatedAt": "2025-06-30T12:51:05.785Z"
  },
  {
    "id": "b147657a-9592-4794-a37d-591ae8f3a03a",
    "symptom": "Nausea",
    "severityLevel": "Moderate",
    "recommendations": {
      "escalation": "If grade 3-4 or dehydration",
      "monitoring": [
        "Q8h assessment",
        "Weight monitoring"
      ],
      "pharmacological": [
        "Ondansetron 8mg PO q8h",
        "Add dexamethasone 4mg daily"
      ],
      "nonPharmacological": [
        "Dietary modifications",
        "Acupressure"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Antiemesis Guidelines v2.2025",
    "createdAt": "2025-06-30T12:51:05.785Z",
    "updatedAt": "2025-06-30T12:51:05.785Z"
  },
  {
    "id": "846aadba-beae-4b01-a779-26d9e24a664c",
    "symptom": "Nausea",
    "severityLevel": "Severe",
    "recommendations": {
      "escalation": "Consider hospitalization if persistent",
      "monitoring": [
        "Continuous monitoring",
        "Electrolytes",
        "I/O"
      ],
      "pharmacological": [
        "Ondansetron 4mg IV q6h",
        "Dexamethasone 8mg IV",
        "Consider aprepitant"
      ],
      "nonPharmacological": [
        "NPO if vomiting",
        "IV hydration"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Antiemesis Guidelines v2.2025",
    "createdAt": "2025-06-30T12:51:05.785Z",
    "updatedAt": "2025-06-30T12:51:05.785Z"
  },
  {
    "id": "18330e79-59db-4404-a41d-f63d636509f7",
    "symptom": "Dyspnea",
    "severityLevel": "Mild",
    "recommendations": {
      "escalation": "If RR >24 or O2 sat <90%",
      "monitoring": [
        "Respiratory rate",
        "Oxygen saturation"
      ],
      "pharmacological": [
        "Bronchodilators if appropriate",
        "Low-dose morphine 2.5mg PO q4h"
      ],
      "nonPharmacological": [
        "Fan therapy",
        "Positioning",
        "Breathing exercises"
      ]
    },
    "evidenceLevel": "Category 2A",
    "guidelineSource": "NCCN Palliative Care Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:05.785Z",
    "updatedAt": "2025-06-30T12:51:05.785Z"
  },
  {
    "id": "95fe88cf-7f19-45f0-ad46-2b2667c70e99",
    "symptom": "Dyspnea",
    "severityLevel": "Moderate",
    "recommendations": {
      "escalation": "If respiratory distress or hypoxemia",
      "monitoring": [
        "Continuous pulse oximetry",
        "ABG if indicated"
      ],
      "pharmacological": [
        "Morphine 5mg PO q4h",
        "Lorazepam 0.5mg PO q8h PRN"
      ],
      "nonPharmacological": [
        "Oxygen therapy",
        "Fan",
        "Anxiety management"
      ]
    },
    "evidenceLevel": "Category 2A",
    "guidelineSource": "NCCN Palliative Care Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:05.785Z",
    "updatedAt": "2025-06-30T12:51:05.785Z"
  },
  {
    "id": "a0ac5450-f52e-425e-86b6-a36bdb877cf3",
    "symptom": "Dyspnea",
    "severityLevel": "Severe",
    "recommendations": {
      "escalation": "Palliative care consultation urgently",
      "monitoring": [
        "Continuous monitoring",
        "Comfort measures"
      ],
      "pharmacological": [
        "Morphine 10mg PO/IV q2-4h",
        "Anxiolytics",
        "Nebulized morphine"
      ],
      "nonPharmacological": [
        "High-flow oxygen",
        "Positioning",
        "Family presence"
      ]
    },
    "evidenceLevel": "Category 2A",
    "guidelineSource": "NCCN Palliative Care Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:05.785Z",
    "updatedAt": "2025-06-30T12:51:05.785Z"
  },
  {
    "id": "94324107-52e4-4da4-b167-18eb3ea612b6",
    "symptom": "Fatigue",
    "severityLevel": "Mild",
    "recommendations": {
      "escalation": "If interfering with ADLs",
      "monitoring": [
        "Daily energy levels",
        "Activity tolerance"
      ],
      "pharmacological": [
        "Correct reversible causes",
        "Consider methylphenidate"
      ],
      "nonPharmacological": [
        "Energy conservation",
        "Light exercise",
        "Sleep hygiene"
      ]
    },
    "evidenceLevel": "Category 2A",
    "guidelineSource": "NCCN Cancer-Related Fatigue Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:05.785Z",
    "updatedAt": "2025-06-30T12:51:05.785Z"
  },
  {
    "id": "61ba3852-9b7e-48ce-befa-80c29da36346",
    "symptom": "Fatigue",
    "severityLevel": "Moderate",
    "recommendations": {
      "escalation": "If severe impact on quality of life",
      "monitoring": [
        "Weekly assessment",
        "Functional status"
      ],
      "pharmacological": [
        "Methylphenidate 5mg BID",
        "Modafinil 100mg daily"
      ],
      "nonPharmacological": [
        "Structured exercise program",
        "Cognitive behavioral therapy"
      ]
    },
    "evidenceLevel": "Category 2A",
    "guidelineSource": "NCCN Cancer-Related Fatigue Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:05.785Z",
    "updatedAt": "2025-06-30T12:51:05.785Z"
  },
  {
    "id": "1924fa23-ce99-495a-b245-45eebc03828a",
    "symptom": "Constipation",
    "severityLevel": "Mild",
    "recommendations": {
      "escalation": "If no BM >3 days",
      "monitoring": [
        "Daily bowel movements",
        "Abdominal assessment"
      ],
      "pharmacological": [
        "Docusate 100mg BID",
        "Senna 2 tabs daily"
      ],
      "nonPharmacological": [
        "Increased fiber",
        "Hydration",
        "Activity"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Palliative Care Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:05.785Z",
    "updatedAt": "2025-06-30T12:51:05.785Z"
  },
  {
    "id": "3ea55256-6d73-40ca-8792-022a39f8fa3b",
    "symptom": "Constipation",
    "severityLevel": "Moderate",
    "recommendations": {
      "escalation": "If impaction suspected",
      "monitoring": [
        "Daily assessment",
        "Abdominal distension"
      ],
      "pharmacological": [
        "Bisacodyl 10mg daily",
        "Polyethylene glycol 17g daily"
      ],
      "nonPharmacological": [
        "Dietary modifications",
        "Abdominal massage"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Palliative Care Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:05.785Z",
    "updatedAt": "2025-06-30T12:51:05.785Z"
  },
  {
    "id": "1595ce81-c6d7-439e-91d2-66d1ef6011ea",
    "symptom": "Pain",
    "severityLevel": "Mild (1-3)",
    "recommendations": {
      "escalation": "If pain >3/10 or affecting function",
      "monitoring": [
        "Daily pain scores",
        "Functional assessment"
      ],
      "pharmacological": [
        "Acetaminophen 1000mg q6h",
        "NSAIDs if appropriate"
      ],
      "nonPharmacological": [
        "Heat/cold therapy",
        "Gentle exercise",
        "Relaxation techniques"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Adult Cancer Pain Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:32.976Z",
    "updatedAt": "2025-06-30T12:51:32.976Z"
  },
  {
    "id": "3b004a8e-6039-4795-8ab6-3bc9b4b97103",
    "symptom": "Pain",
    "severityLevel": "Moderate (4-6)",
    "recommendations": {
      "escalation": "If pain >6/10 or uncontrolled",
      "monitoring": [
        "Q4h pain assessment",
        "Bowel regimen",
        "Sedation score"
      ],
      "pharmacological": [
        "Morphine 5-10mg PO q4h PRN",
        "Oxycodone 5mg PO q4h PRN"
      ],
      "nonPharmacological": [
        "Physical therapy",
        "TENS unit",
        "Mindfulness"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Adult Cancer Pain Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:32.976Z",
    "updatedAt": "2025-06-30T12:51:32.976Z"
  },
  {
    "id": "cd6e84f4-5629-4e72-8a2f-d6ae38f3eacd",
    "symptom": "Pain",
    "severityLevel": "Severe (7-10)",
    "recommendations": {
      "escalation": "Pain specialist consultation within 24h",
      "monitoring": [
        "Hourly assessment",
        "Respiratory status",
        "Sedation"
      ],
      "pharmacological": [
        "Morphine 10-20mg PO q4h",
        "Consider IV/SQ route",
        "Breakthrough dosing"
      ],
      "nonPharmacological": [
        "Immediate comfort measures",
        "Family support"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Adult Cancer Pain Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:32.976Z",
    "updatedAt": "2025-06-30T12:51:32.976Z"
  },
  {
    "id": "d5a5fbc4-5961-44c9-bd9e-413c5f9af6af",
    "symptom": "Nausea",
    "severityLevel": "Mild",
    "recommendations": {
      "escalation": "If persistent >48h or affecting nutrition",
      "monitoring": [
        "Daily symptom assessment",
        "Nutritional intake"
      ],
      "pharmacological": [
        "Ondansetron 4mg PO q8h PRN",
        "Metoclopramide 10mg PO qid"
      ],
      "nonPharmacological": [
        "Small frequent meals",
        "Ginger tea",
        "Aromatherapy"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Antiemesis Guidelines v2.2025",
    "createdAt": "2025-06-30T12:51:32.976Z",
    "updatedAt": "2025-06-30T12:51:32.976Z"
  },
  {
    "id": "abbb1677-df90-4ec8-bb06-efa9d13ed7c4",
    "symptom": "Nausea",
    "severityLevel": "Moderate",
    "recommendations": {
      "escalation": "If grade 3-4 or dehydration",
      "monitoring": [
        "Q8h assessment",
        "Weight monitoring"
      ],
      "pharmacological": [
        "Ondansetron 8mg PO q8h",
        "Add dexamethasone 4mg daily"
      ],
      "nonPharmacological": [
        "Dietary modifications",
        "Acupressure"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Antiemesis Guidelines v2.2025",
    "createdAt": "2025-06-30T12:51:32.976Z",
    "updatedAt": "2025-06-30T12:51:32.976Z"
  },
  {
    "id": "037245e3-6192-4b88-9cd0-954fc3ab64f3",
    "symptom": "Nausea",
    "severityLevel": "Severe",
    "recommendations": {
      "escalation": "Consider hospitalization if persistent",
      "monitoring": [
        "Continuous monitoring",
        "Electrolytes",
        "I/O"
      ],
      "pharmacological": [
        "Ondansetron 4mg IV q6h",
        "Dexamethasone 8mg IV",
        "Consider aprepitant"
      ],
      "nonPharmacological": [
        "NPO if vomiting",
        "IV hydration"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Antiemesis Guidelines v2.2025",
    "createdAt": "2025-06-30T12:51:32.976Z",
    "updatedAt": "2025-06-30T12:51:32.976Z"
  },
  {
    "id": "9491df42-6d1f-4cd9-9b66-7f3cd0be8575",
    "symptom": "Dyspnea",
    "severityLevel": "Mild",
    "recommendations": {
      "escalation": "If RR >24 or O2 sat <90%",
      "monitoring": [
        "Respiratory rate",
        "Oxygen saturation"
      ],
      "pharmacological": [
        "Bronchodilators if appropriate",
        "Low-dose morphine 2.5mg PO q4h"
      ],
      "nonPharmacological": [
        "Fan therapy",
        "Positioning",
        "Breathing exercises"
      ]
    },
    "evidenceLevel": "Category 2A",
    "guidelineSource": "NCCN Palliative Care Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:32.976Z",
    "updatedAt": "2025-06-30T12:51:32.976Z"
  },
  {
    "id": "d0afa5d3-3a10-4d47-b595-3f0392b07c9c",
    "symptom": "Dyspnea",
    "severityLevel": "Moderate",
    "recommendations": {
      "escalation": "If respiratory distress or hypoxemia",
      "monitoring": [
        "Continuous pulse oximetry",
        "ABG if indicated"
      ],
      "pharmacological": [
        "Morphine 5mg PO q4h",
        "Lorazepam 0.5mg PO q8h PRN"
      ],
      "nonPharmacological": [
        "Oxygen therapy",
        "Fan",
        "Anxiety management"
      ]
    },
    "evidenceLevel": "Category 2A",
    "guidelineSource": "NCCN Palliative Care Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:32.976Z",
    "updatedAt": "2025-06-30T12:51:32.976Z"
  },
  {
    "id": "07c8f4db-d7b9-4a27-8232-37cb0f02ba37",
    "symptom": "Dyspnea",
    "severityLevel": "Severe",
    "recommendations": {
      "escalation": "Palliative care consultation urgently",
      "monitoring": [
        "Continuous monitoring",
        "Comfort measures"
      ],
      "pharmacological": [
        "Morphine 10mg PO/IV q2-4h",
        "Anxiolytics",
        "Nebulized morphine"
      ],
      "nonPharmacological": [
        "High-flow oxygen",
        "Positioning",
        "Family presence"
      ]
    },
    "evidenceLevel": "Category 2A",
    "guidelineSource": "NCCN Palliative Care Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:32.976Z",
    "updatedAt": "2025-06-30T12:51:32.976Z"
  },
  {
    "id": "f19c6071-1965-4770-80ee-503b64ce65a6",
    "symptom": "Fatigue",
    "severityLevel": "Mild",
    "recommendations": {
      "escalation": "If interfering with ADLs",
      "monitoring": [
        "Daily energy levels",
        "Activity tolerance"
      ],
      "pharmacological": [
        "Correct reversible causes",
        "Consider methylphenidate"
      ],
      "nonPharmacological": [
        "Energy conservation",
        "Light exercise",
        "Sleep hygiene"
      ]
    },
    "evidenceLevel": "Category 2A",
    "guidelineSource": "NCCN Cancer-Related Fatigue Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:32.976Z",
    "updatedAt": "2025-06-30T12:51:32.976Z"
  },
  {
    "id": "e57e2085-9d9c-4787-905e-f08cad3fe52f",
    "symptom": "Fatigue",
    "severityLevel": "Moderate",
    "recommendations": {
      "escalation": "If severe impact on quality of life",
      "monitoring": [
        "Weekly assessment",
        "Functional status"
      ],
      "pharmacological": [
        "Methylphenidate 5mg BID",
        "Modafinil 100mg daily"
      ],
      "nonPharmacological": [
        "Structured exercise program",
        "Cognitive behavioral therapy"
      ]
    },
    "evidenceLevel": "Category 2A",
    "guidelineSource": "NCCN Cancer-Related Fatigue Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:32.976Z",
    "updatedAt": "2025-06-30T12:51:32.976Z"
  },
  {
    "id": "7ab7b70d-e06a-457b-b97e-9edf17e571a5",
    "symptom": "Constipation",
    "severityLevel": "Mild",
    "recommendations": {
      "escalation": "If no BM >3 days",
      "monitoring": [
        "Daily bowel movements",
        "Abdominal assessment"
      ],
      "pharmacological": [
        "Docusate 100mg BID",
        "Senna 2 tabs daily"
      ],
      "nonPharmacological": [
        "Increased fiber",
        "Hydration",
        "Activity"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Palliative Care Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:32.976Z",
    "updatedAt": "2025-06-30T12:51:32.976Z"
  },
  {
    "id": "dec154cc-7049-4b33-a724-47d40e285d65",
    "symptom": "Constipation",
    "severityLevel": "Moderate",
    "recommendations": {
      "escalation": "If impaction suspected",
      "monitoring": [
        "Daily assessment",
        "Abdominal distension"
      ],
      "pharmacological": [
        "Bisacodyl 10mg daily",
        "Polyethylene glycol 17g daily"
      ],
      "nonPharmacological": [
        "Dietary modifications",
        "Abdominal massage"
      ]
    },
    "evidenceLevel": "Category 1",
    "guidelineSource": "NCCN Palliative Care Guidelines v1.2025",
    "createdAt": "2025-06-30T12:51:32.976Z",
    "updatedAt": "2025-06-30T12:51:32.976Z"
  }
]